studies provide compelling evidence that semaglutide use in orthopedic surgery is associated with lower rates of infection, readmission, and revision surgery, likely due to improved metabolic control, reductions in systemic inflammation, and weight loss-driven perioperative risk reduction
Other studies have not found an increased risk of FG with SGLT2 inhibitors (217,218)
The Precision Peptide Genetic Test reveals predispositions in peptide pathway genesnot a guaranteed prediction of exact medication response or outcome
Add nourishing foods, eat real meals most of the time, and stay flexible
Medication should not be the first course of action, and current evidence does not support its effectiveness as a sole form of treatment, nor do medical guidelines recommend such use